المنشورات طباعة Ahmed ME, Lee MS, Mahmoud AM, Joshi VB, Gopalakrishna A, Bole R, Haloi R, Kendi AT, Bold MS, Bryce AH, Karnes RJ, Kwon ED, Childs DS, Andrews JR. Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024 Jun; 27 (2):334-338 Epub 2023 Nov 07 View PubMed Parreau S, Espitia O, Bold MS, Frota Lima LM, Lades G, Bois M, Assaraf M, Saadoun D, Koster MJ, Ly KH, Weyand CM, Warrington KJ, Liozon E. Relationship between histopathological features of non-infectious aortitis and the results of pre-operative 18F-FDG-PET/CT: a retrospective study of 16 patients. Clin Exp Rheumatol. 2023 Apr; 41 (4):916-921 Epub 2023 Feb 01 View PubMed Alamiri J, Britton CJ, Ahmed ME, Andrews JR, Higa JL, Dundar A, Karnes RJ, Kwon E, Lowe VJ, Kendi AT, Bold MS, Pagliaro LC. Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis. Prostate. 2022 Dec; 82(16):1483-1490. Epub 2022 Sep 11. View PubMed Jimbo M, Andrews JR, Ahmed ME, Dundar A, Karnes RJ, Bryce AH, Kendi AT, Kwon ED, Lowe VJ, Bold MS. Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy. Prostate. 2022 Jan; 82(1):41-48. Epub 2021 Oct 11. View PubMed Bold MS, Boyum JH, Potretzke AM, Rose CH, Atwell TD, Sviggum EB, Goss BC, Brown DL. Detection of distal ureteral stones in pregnancy using transvaginal ultrasound. J Ultrasound. 2021 Dec; 24 (4):397-402 Epub 2020 July 14 View PubMed Zhang H, Orme JJ, Abraha F, Stish BJ, Lowe VJ, Lucien F, Tryggestad EJ, Bold MS, Pagliaro LC, Choo CR, Brinkmann DH, Iott MJ, Davis BJ, Quevedo JF, Harmsen WS, Costello BA, Johnson GB, Nathan MA, Olivier KR, Pisansky TM, Kwon ED, Dong H, Park SS. Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in (11)C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2021 Dec 1; 27 (23):6376-6383 Epub 2021 Sept 30 View PubMed Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call TG, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Fonder AL, Chanan-Khan AA, Van Dyke DL, Slager SL, Kay NE, Ding W, Leis JF, Parikh SA. The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor. Haematologica 2020 Nov 1; 105 (11):2675-2678 Epub 2020 Nov 01 View PubMed Wang Y, Rabe KG, Bold MS, Shi M, Hanson CA, Schwager SM, Call TG, Kenderian SS, Muchtar E, Hayman SR, Koehler AB, Fonder AL, Chanan-Khan AA, Van Dyke DL, Slager SL, Kay NE, Ding W, Leis JF, Parikh SA. The role of 18F-FDG-PET in detecting Richter's transformation of chronic lymphocytic leukemia in patients receiving therapy with a B-cell receptor inhibitor. Haematologica. 2020 Jan 23 [Epub ahead of print] View PubMed Dundar A, Bold MS, Agac B, Kendi AT, Friedman SN. Stroke detection with 3 different PET tracers. Radiol Case Rep. 2019 Nov; 14 (11):1447-1451 Epub 2019 Oct 01 View PubMed Villatoro-Villar M, Bold MS, Warrington KJ, Crowson CS, Goyal G, Shah M, Go RS, Koster MJ. Arterial involvement in Erdheim-Chester disease: A retrospective cohort study. Medicine (Baltimore). 2018 Dec; 97 (49):e13452 View PubMed Huang J, Bold M, Rajebi MR. Endovascular retrieval of Greenfield IVC filters 13 and 19 years post placement without major complication. J Radiol Case Rep. 2017 Jun; 11 (6):15-25 Epub 2017 June 30 View PubMed PST-20510667 الصفحة الرئيسية المنشورات